SOA Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
SOA Wealth Advisors's BMY Position: Q2 2026 in Review
SOA Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $35.2K and leaving 3,984 shares worth $230K. The position accounts for 0.04% of the portfolio, ranked #192.
SOA Wealth Advisors first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $307K in Q1 2025. 857 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SOA Wealth Advisors held 3,984 shares of Bristol-Myers Squibb worth $230K as of Q2 2026.
- SOA Wealth Advisors sold 613 Bristol-Myers Squibb shares in Q2 2026, an estimated $35.2K.
- Bristol-Myers Squibb made up 0.04% of SOA Wealth Advisors's portfolio in Q2 2026, its #192 holding.
- SOA Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
- SOA Wealth Advisors's Bristol-Myers Squibb position peaked at $307K in Q1 2025.
- 857 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.